Effects of dulaglutide on endothelial progenitor cells and arterial elasticity in patients with type 2 diabetes mellitus

BACKGROUND: Randomised controlled trial showed that dulaglutide can reduce the risk of atherosclerotic cardiovascular disease (ASCVD) in patients with type 2 diabetes mellitus (T2DM), but the underlying mechanisms remain unclear. This study aimed to investigate the effect of dulaglutide on the numbe...

Descripción completa

Detalles Bibliográficos
Autores principales: Xie, Dandan, Li, Yutong, Xu, Murong, Zhao, Xiaotong, Chen, Mingwei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9533545/
https://www.ncbi.nlm.nih.gov/pubmed/36199064
http://dx.doi.org/10.1186/s12933-022-01634-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9533545/
https://www.ncbi.nlm.nih.gov/pubmed/36199064
http://dx.doi.org/10.1186/s12933-022-01634-1

Ejemplares similares